These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10142816)

  • 1. Will antitrust cops bust billion-dollar drug deals?
    Barnett AA
    J Am Health Care; 1994; 4(5):5-7. PubMed ID: 10142816
    [No Abstract]   [Full Text] [Related]  

  • 2. Competition and antitrust enforcement in the changing pharmaceutical marketplace.
    Whitener MD
    Food Drug Law J; 1995; 50(2):301-7. PubMed ID: 10342998
    [No Abstract]   [Full Text] [Related]  

  • 3. Sword or shield? An overview and competitive analysis of the marketing of "authorized generics".
    Zain S
    Food Drug Law J; 2007; 62(4):739-77. PubMed ID: 18557229
    [No Abstract]   [Full Text] [Related]  

  • 4. Unsettling drug patent settlements: a framework for presumptive illegality.
    Carrier MA
    Mich Law Rev; 2009 Oct; 108(1):37-80. PubMed ID: 20535881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reanalyzing reverse payment settlements: a solution to the patentee's dilemma.
    Wang Z
    Cornell Law Rev; 2014 Jul; 99(5):1227-58. PubMed ID: 25112001
    [No Abstract]   [Full Text] [Related]  

  • 6. Brand-name drug manufacturers risk antitrust violations by slowing generic production through patent layering.
    Paine CS
    Seton Hall Law Rev; 2003; 33(2):479-510. PubMed ID: 12715807
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmaceutical patent settlements: the antitrust risks.
    Balto DA
    Food Drug Law J; 2000; 55(3):321-41. PubMed ID: 11824464
    [No Abstract]   [Full Text] [Related]  

  • 8. Hoechst plans divestitures to gain FTC nod.
    Scott L
    Mod Healthc; 1995 Sep; 25(39):32. PubMed ID: 10151416
    [No Abstract]   [Full Text] [Related]  

  • 9. Feds state their case. FTC: deals would end distributors' incentive to cut prices.
    Hensley S
    Mod Healthc; 1998 Mar; 28(11):28. PubMed ID: 10178255
    [No Abstract]   [Full Text] [Related]  

  • 10. The FTC v. Actavis roadmap: a guide to properly applying the rule of reason standard in reverse payment cases.
    Sharkey N
    J Leg Med; 2014; 35(3):445-66. PubMed ID: 25207633
    [No Abstract]   [Full Text] [Related]  

  • 11. Antitrust issues in the settlement of pharmaceutical patent disputes, Part II.
    Leary TB
    J Health Law; 2001; 34(4):657-71. PubMed ID: 11833411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bundling patented drugs and medical services: an antitrust analysis.
    Hurwitz MA
    Spec Law Dig Health Care Law; 1992 Jan; (155):7-39. PubMed ID: 10115664
    [No Abstract]   [Full Text] [Related]  

  • 13. Antitrust, Market Exclusivity, and Transparency in the Pharmaceutical Industry.
    Sinha MS; Curfman GD; Carrier MA
    JAMA; 2018 Jun; 319(22):2271-2272. PubMed ID: 29801104
    [No Abstract]   [Full Text] [Related]  

  • 14. Judge dismisses antitrust suit against GlaxoSmithKline.
    AIDS Policy Law; 2003 Mar; 18(6):5. PubMed ID: 12712928
    [No Abstract]   [Full Text] [Related]  

  • 15. Inflation. Price hikes on AIDS drug not protected by antitrust laws.
    AIDS Policy Law; 2005 Sep; 20(18):6. PubMed ID: 16208823
    [No Abstract]   [Full Text] [Related]  

  • 16. Mergers. Big ... bigger ... biggest.
    Serb C
    Hosp Health Netw; 1997 Dec; 71(23):46, 48. PubMed ID: 9413316
    [No Abstract]   [Full Text] [Related]  

  • 17. Merck, SmithKline deals probed.
    Scott L
    Mod Healthc; 1994 Nov; 24(47):40. PubMed ID: 10138243
    [No Abstract]   [Full Text] [Related]  

  • 18. FTC approves Lilly's PCS purchase.
    Scott L
    Mod Healthc; 1995 Aug; 25(32):30. PubMed ID: 10144477
    [No Abstract]   [Full Text] [Related]  

  • 19. Playing monopoly? FTC probes mammoth drug distributor merger.
    Becker C
    Mod Healthc; 2001 May; 31(20):34. PubMed ID: 11386133
    [No Abstract]   [Full Text] [Related]  

  • 20. Antitrust cops may get backup. FTC may establish merger section to investigate new and old hospital deals.
    Taylor M
    Mod Healthc; 2002 May; 32(18):12-3. PubMed ID: 12037919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.